Moreover, low expression levels of ALDH1A1 (Fig. 5b) or high expression levels of ALDH1A3 (Fig. 5c) are associated with unfavorable prognostic factors in NB (i.e., age at diagnosis >18 months, and stage 4 disease). This evidence concerns the gene ALDH1A3 and neuroblastoma.